The first Oncology Joint Research Office in my country is settled in Tianjin
Release time: 2010-05-14 & nbsp & nbsp & nbsp Source:
May 11，"Tianjin Medical University Affiliated Oncology Hospital ---- Johnson & Johnson Pharmaceutical R & D Center Oncology Joint Research Office" stake betting appco-established stake online sports bettingby Tianjin Medical University and Johnshill Pharmaceutical R & D Group in the United States was established，The first "Oncology Joint Research Office" to reach the international advanced level。
It is reported，This time the Tianjin Medical University Cancer Hospital and Johnson，Johnson & Johnson will invest $ 4 million in the project for purchasing instrument equipment、Test materials and research room operating costs，The Cancer Hospital of Tianjin Medical University will be responsible for providing experimental venues、Researchers and conventional reagents。
American Johnson & Johnson is the world's largest medical, health care and consumer care product company，Picks up in the world's pharmaceutical industry，Have a powerful pharmaceutical research and development system，More than ten medical fields including new drug research and development involved in the development of anti -tumor drugs。The Cancer Hospital of Tianjin Medical University has the largest domestic、The stake sports betting appmost Stake Sports Bettingadvanced tumor tissue specimen library，and with strong clinical diagnosis and treatment technical strength and rich scientific and technological resources。
The person in charge of the "Oncology Joint Research Room" Yu Jinpu said in an interview with China Daily reporters，"Research Room" will establish a "3D stereo in vitro model" for the first time，This model breaks through the limitations of previous plane models，Make it closer to the function of the human body。In addition，"Research Room" will also establish an individualized body model，Tumor taken from the patient directly as a research material。Through the body、Comprehensive evaluation of two sets of in vitro models，R & D regional and global low toxicity with regional characteristics、High -efficiency anti -tumor targeted therapy drugs。
"This will greatly accelerate the speed and rhythm of drug development，Short the application cycle of new drugs，Make the diagnosis and treatment of tumors more accurate My stake betting appstake online sports bettingand effective。"Yujinpu introduced。
"The completion of the Jiansheng Pharmaceutical R & D Center Oncology Joint Research Office"，It will be an innovative mode with an orderly combination of basic research and clinical trials。By fully integrating the personnel of both parties in personnel、Equipment、Technical advantageous resources，Realize the strong jone，Coordinated development。The establishment of the laboratory，Not only will it greatly improve the research and development level of Tianjin's pharmaceutical technology industry，Set up a platform for the transformation of high -tech scientific research results，It will further promote the integration of my country in the field of tumor drug research and development with international advanced levels。
It is reported，This time the Tianjin Medical University Cancer Hospital and Johnson，Johnson & Johnson will invest $ 4 million in the project for purchasing instrument equipment、Test materials and research room operating costs，The Cancer Hospital of Tianjin Medical University will be responsible for providing experimental venues、Researchers and conventional reagents。
American Johnson & Johnson is the world's largest medical, health care and consumer care product company，Picks up in the world's pharmaceutical industry，Have a powerful pharmaceutical research and development system，More than ten medical fields including new drug research and development involved in the development of anti -tumor drugs。The Cancer Hospital of Tianjin Medical University has the largest domestic、The stake sports betting appmost Stake Sports Bettingadvanced tumor tissue specimen library，and with strong clinical diagnosis and treatment technical strength and rich scientific and technological resources。
The person in charge of the "Oncology Joint Research Room" Yu Jinpu said in an interview with China Daily reporters，"Research Room" will establish a "3D stereo in vitro model" for the first time，This model breaks through the limitations of previous plane models，Make it closer to the function of the human body。In addition，"Research Room" will also establish an individualized body model，Tumor taken from the patient directly as a research material。Through the body、Comprehensive evaluation of two sets of in vitro models，R & D regional and global low toxicity with regional characteristics、High -efficiency anti -tumor targeted therapy drugs。
"This will greatly accelerate the speed and rhythm of drug development，Short the application cycle of new drugs，Make the diagnosis and treatment of tumors more accurate My stake betting appstake online sports bettingand effective。"Yujinpu introduced。
"The completion of the Jiansheng Pharmaceutical R & D Center Oncology Joint Research Office"，It will be an innovative mode with an orderly combination of basic research and clinical trials。By fully integrating the personnel of both parties in personnel、Equipment、Technical advantageous resources，Realize the strong jone，Coordinated development。The establishment of the laboratory，Not only will it greatly improve the research and development level of Tianjin's pharmaceutical technology industry，Set up a platform for the transformation of high -tech scientific research results，It will further promote the integration of my country in the field of tumor drug research and development with international advanced levels。
